|
NSMCE4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.487800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.365050E-01 |
| Normal-vs-Stage2 |
4.545000E-01 |
| Normal-vs-Stage3 |
6.880800E-03 |
| Normal-vs-Stage4 |
9.871600E-02 |
| Stage1-vs-Stage2 |
6.705800E-01 |
| Stage1-vs-Stage3 |
1.676230E-01 |
| Stage1-vs-Stage4 |
5.389800E-01 |
| Stage2-vs-Stage3 |
1.410240E-01 |
| Stage2-vs-Stage4 |
4.208800E-01 |
| Stage3-vs-Stage4 |
7.724400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.113830E-01 |
| Normal-vs-AfricanAmerican |
4.310800E-01 |
| Normal-vs-Asian |
7.445000E-01 |
| Caucasian-vs-AfricanAmerican |
2.904200E-01 |
| Caucasian-vs-Asian |
6.748200E-01 |
| AfricanAmerican-vs-Asian |
9.512200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.282000E-02 |
| Normal-vs-Female |
8.765200E-01 |
| Male-vs-Female |
3.242100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.981600E-02 |
| Normal-vs-Extreme_Weight |
5.808500E-02 |
| Normal-vs-Obese |
3.665200E-01 |
| Normal-vs-Extreme_Obese |
5.914400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.762800E-01 |
| Normal_Weight-vs-Obese |
3.218000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.438200E-01 |
| Extreme_Weight-vs-Obese |
2.610600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.924600E-01 |
| Obese-vs-Extreme_Obese |
2.337800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.123800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.239400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.141760E-01 |
| Normal-vs-Age(81-100Yrs) |
2.980400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.951200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.861800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.392610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.636800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.437970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.812200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.080800E-01 |
| Normal-VS-Type2 PRCC |
8.578600E-03 |
| Normal-VS-KIRP CIMP |
1.453000E-01 |
| Normal-VS-Unclassified PRCC |
7.458500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.975800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.840200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.406000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.583000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.029600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.341000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.082400E-02 |
| Normal-vs-N1 |
9.129900E-02 |
| Normal-vs-N2 |
2.098600E-01 |
| N0-vs-N1 |
7.917400E-01 |
| N0-vs-N2 |
1.193170E-01 |
| N1-vs-N2 |
1.032960E-01 |
|
|
